| 摘要 |
<p>The invention relates to a transdermal therapeutic system (TTS), preferably in the form of a transdermal plaster containing an active substance, an agent which can destroy the active substance, and a means which brings the active substance e.g. buprenorphine, and the agent, e.g. potassium permanganate, into contact when the TTS is removed from the skin of the patient, thereby causing the active substance to be destroyed.</p> |
